Company intelligence / Profile preview

Koslapp Therapeutics

Not specified, Not specified, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Other

Overview

No public clinical results or pipeline data are currently disclosed for Koslapp Therapeutics. The company is led by Dr. Lloyd Klickstein, an experienced executive with a strong background in immunology and translational medicine[5][6][7].

Therapeutic areas: Immunology
Modalities: Not specified in available sources; likely includes biologics or small molecules given leadership background in immunology and drug development[5][6].
Industry: Biotech

Partnerships

No partnerships have been publicly announced as of May 2025.

Beyond the preview

Go deeper on Koslapp Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Koslapp Therapeutics.

Explore the full profile